Realcan Pharmaceutical Group Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Ruikang Pharmaceutical Group Co., Ltd. is a comprehensive medical service provider that directly sells drugs, medical devices, and medical consumables to medical institutions across the country. At the same time, it has eight major business sectors including drug and equipment circulation, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medicine, professional logistics, and comprehensive devices. Ruikang Pharmaceutical Group was established on September 21, 2004, with over 100 subsidiaries under its umbrella. The company was listed on the Shenzhen A-share market in June 2011, with stock code 002589. Its sales network covers 31 provinces and cities across the country, directly serving nearly 60000 medical institutions, and its business covers almost all leading pharmaceutical equipment circulation enterprises of domestic and foreign manufacturers above designated size. In recent years, the group has adapted to the development needs of the situation and focused on building eight major business sectors, including drug and equipment circulation, academic services, medical diagnosis, financial technology, traditional Chinese medicine, digital medicine, professional logistics, and comprehensive equipment. It has implemented a unified management model of "one command center, ten unified management" and has established business relationships with nearly 30000 domestic and foreign drug and equipment production enterprises, becoming an important partner of major multinational pharmaceutical enterprises in China. 2021 is the beginning year of the 14th Five Year Plan and a year of special importance in China's modernization construction process. Faced with severe industry changes and challenges, Ruikang Pharmaceutical has strengthened its strategic awareness, innovation awareness, and crisis awareness, adhered to self innovation, strengthened strategic focus, and focused on the pharmaceutical and health industry, focusing on the core business of pharmaceuticals; Taking technology as the trend, embracing medical technology innovation and incubating emerging business models; Using capital as a tool to build a pharmaceutical and health ecosystem, and unleash the value of industrial capital; With innovation as the soul, we maintain sustainable innovation momentum, continuously inject development vitality, and strive to create the "most dynamic pharmaceutical and health ecological resource integrator in China", making new contributions to the cause of people's health. |
| Headquarter | Yantai |
| Establish Date | 9/21/2004 |
| Listed Code | 002589.SZ |
| Listed Date | 6/10/2011 |
| Chairman | Han Xu. |
| CEO | Han Xu, Zhang Renhua. |
| Website | www.realcan.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
